--------------------------------------------------------------------------------

Exhibit 10.1

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this "Agreement") is dated as of May 27,
2010, by and among Nutrastar International Inc., a Nevada corporation (the
"Company"), and each purchaser identified on the signature pages hereto (each,
including its successors and assigns, a "Purchaser" and collectively, the
"Purchasers").

WHEREAS, subject to the terms and conditions set forth in this Agreement and
pursuant to Section 4(2) of the Securities Act of 1933, as amended (the
"Securities Act"), and Regulation D promulgated thereunder ("Regulation D"), or
pursuant to Regulation S promulgated thereunder ("Regulation S"), the Company
desires to issue and sell to each Purchaser, and each Purchaser, severally and
not jointly, desires to purchase from the Company, securities of the Company as
more fully described in this Agreement; and

WHEREAS, Gilford Securities Incorporated is acting as the placement agent for
the Company (the "Placement Agent").

NOW, THEREFORE, in consideration of the mutual covenants contained in this
Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and each Purchaser agree
as follows:

ARTICLE I
DEFINITIONS

1.1

Definitions. In addition to the terms defined elsewhere in this Agreement, the
following terms have the meanings set forth in this Section 1.1:

"Accredited Investor" means an "accredited investor" as defined in Rule 501(a)
of Regulation D.

"Action" shall have the meaning ascribed to such term in Section 3.1(j) .

"Affiliate" means a Person that, directly or indirectly through one or more
intermediaries, Controls or is Controlled by or is under common Control with the
Person specified.

"Aggregate Purchase Price" shall have the meaning ascribed to such term in
Section 2.1.

"Agreement" shall have the meaning ascribed to such term in the preamble.

"ARC China" means ARC China, Inc., a Shanghai corporation, a consultant to the
Purchasers.

"Board of Directors" means the board of directors of the Company.

"Brownstein" means Brownstein Hyatt Farber Schreck, LLP, with offices located at
410 17th Street, Suite 2200, Denver, Colorado 80202.

--------------------------------------------------------------------------------

"Business Day" means any day except Saturday, Sunday, any day which is a federal
legal holiday in the United States or any day on which banking institutions in
the State of New York are authorized or required by law or other governmental
action to close.

“Certificate of Designation” means the amended and restated Certificate of
Designation to be filed prior to the Closing by the Company with the Secretary
of State of Nevada, in the form of Exhibit A attached hereto.

"CFO Compensation Cash" shall have the meaning ascribed to such term in Section
2.2.

"CFO Restricted Shares" shall have the meaning ascribed to such term in Section
4.13.

"Closing" shall have the meaning ascribed to such term in Section 2.1.

"Closing Date" means the date on which the Closing occurs.

"Commission" means the United States Securities and Exchange Commission.

“Commission Comments” means written comments pertaining solely to Rule 415 which
are received by the Company from the Commission to a filed Registration
Statement, which either (i) requires the Company to limit the number of
Registrable Securities which may be included therein to a number which is less
than the number sought to be included thereon as filed with the Commission or
(ii) requires the Company to either exclude Registrable Securities held by
specified Purchasers or deem such Purchasers to be underwriters with respect to
Registrable Securities they seek to include in such Registration Statement.

"Common Stock" shall have the meaning ascribed to such term in Section 2.1.

"Common Stock Equivalents" means any securities of the Company or the
Subsidiaries which would entitle the holder thereof to acquire at any time
Common Stock, including, without limitation, any debt, preferred stock, rights,
options, warrants or other instrument that is at any time convertible into or
exercisable or exchangeable for, or otherwise entitles the holder thereof to
receive Common Stock.

"Company" shall have the meaning set forth in the preamble.

"Company Counsel" means Pillsbury Winthrop Shaw Pittman LLP, with an office
located on 50 Fremont Street, San Francisco, California 94105-2228.

"Control" (including the terms "Controlled by" and "under common Control with")
means the possession, direct or indirect, of the power to direct or cause the
direction of the management and policies of a Person, whether through the
ownership of voting securities, by contract, or otherwise.

2

--------------------------------------------------------------------------------

"Disclosure Schedules" shall mean the schedules attached hereto, including the
schedules as described in Sections 3.1 and 3.2.

"Effective Date" means the date that the Registration Statement filed by the
Company pursuant to Section 4.17 is first declared effective by the Commission.

"Effectiveness Period" shall have the meaning ascribed to such term in Section
4.17(a)(iv) .

"ERISA" shall have the meaning ascribed to such term in Section 3.1(hh) .

"Escrow Account" means the escrow account maintained by the Escrow Agent for the
deposit of the Purchase Price and for the retention of the IR Cash and the CFO
Compensation Cash.

"Escrow Agent" means Corporate Stock Transfer, Inc.

"Escrow Agreement" means the escrow agreement entered into on or before the date
hereof by and among the Company, ARC China, the Placement Agent, the Escrow
Agent and United Western Bank, pursuant to which the Purchasers shall deposit
the Purchase Price with the Escrow Agent in accordance with the terms set forth
in this Agreement and for the retention of the IR Cash and the CFO Compensation
Cash for dissemination to investor relations firms and the Qualified CFO,
respectively, as may be mutually agreed upon and at such times as determined by
the Company and ARC China.

"Evaluation Date" shall have the meaning ascribed to such term in Section 3.1(q)
.

"Exchange Act" means the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder.

"Filing Date" shall have the meaning ascribed to such term in Section 4.17(a)(i)
.

"GAAP" means the United States generally accepted accounting principles applied
on a consistent basis during the periods involved.

"Indebtedness" shall have the meaning ascribed to such term in Section 3.1(z) .

"Intellectual Property Rights" shall have the meaning ascribed to such term in
Section 3.1(o) .

"IR Cash" shall have the meaning ascribed to such term in Section 2.2.

"Liens" means any mortgage, lien, pledge, charge, restriction, security
interest, encumbrance, right of first refusal, preemptive right, option, lease,
sublease or other restriction or encumbrance of any kind.

"Liquidated Damages" shall have the meaning ascribed to such term in Section
4.17(a)(v) .

3

--------------------------------------------------------------------------------

"Material Adverse Effect" shall have the meaning assigned to such term in
Section 3.1(b) .

"Material Permits" shall have the meaning ascribed to such term in Section
3.1(m) .

"Non-Registration Event" shall have the meaning ascribed to such term in Section
4.17(a)(v) .

"Person" means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint
stock company, government (or an agency or subdivision thereof) or other entity
of any kind.

"Placement Agent" shall have the meaning ascribed to such term in the Recitals.

"Placement Agent Agreement" means the agreement between the Placement Agent and
the Company dated on or about the date of this Agreement.

"Preferred Stock" shall have the meaning ascribed to such term in Section 2.1.

"Proceeding" means an action, claim, suit, investigation or proceeding
(including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

"Purchase Price" means, as to each Purchaser, the aggregate amount to be paid
for the Securities purchased hereunder as specified below such Purchaser's name
on the signature page of this Agreement and next to the heading "Purchase
Price," in United States dollars and in immediately available funds.

"Purchasers" shall have the meaning set forth in the preamble.

"Purchaser Party" shall have the meaning ascribed to such term in Section 4.9.

"Qualified CFO" shall have the meaning ascribed to such term in Section 4.13.

"Registrable Securities" shall have the meaning ascribed to such term in Section
4.17(a)(i) .

"Registration Statement" means a registration statement meeting the requirements
set forth in Section 4.17 and covering the resale of the Securities by each
Purchaser as provided for in Section 4.17.

"Regulation D" shall have the meaning ascribed to such term in the Recitals.

"Regulation S " shall have the meaning ascribed to such term in the Recitals.

"Required Approvals" shall have the meaning ascribed to such term in Section
3.1(e) .

4

--------------------------------------------------------------------------------

"Required Effective Date" shall have the meaning ascribed to such term in
Section 4.17(a)(i) .

"Required Filing Date" shall have the meaning ascribed to such term in Section
4.17(a)(i) .

"Required Holders" means the Purchasers holding a majority of the Securities
then outstanding.

"Rule 144" means Rule 144 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the
same effect as such Rule.

"SEC Reports" shall have the meaning ascribed to such term in Section 3.1(h) .

"Securities" shall have the meaning ascribed to such term in Section 2.1.

"Securities Act" shall have the meaning ascribed to such term in the Recitals.

“Short Sales” include, without limitation, all “short sales” as defined in Rule
200 promulgated under Regulation SHO under the Exchange Act and all types of
direct and indirect stock pledges, forward sale contracts, options, puts, calls,
swaps and similar arrangements (including on a total return basis), and sales
and other transactions through non-US broker dealers or foreign regulated
brokers.

"Subsidiary" means any subsidiary of the Company as set forth on Schedule 3.1(a)
and shall, where applicable, also include any direct or indirect subsidiary of
the Company formed or acquired after the date hereof.

"To the knowledge of the Company" means the actual knowledge of the management
of the Company and such knowledge that the management of the Company would have
obtained after a reasonable inquiry or investigation under the circumstances.

"Trading Day" means a day on which the principal Trading Market is open for
trading.

"Trading Market" means the following markets or exchanges on which the Common
Stock is listed or quoted for trading on the date in question: the NYSE Amex
Equities, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global
Select Market, the New York Stock Exchange or the OTC Bulletin Board.

"Transaction Documents" means this Agreement, the Certificate of Designation,
the Escrow Agreement, the agreement with the Placement Agent, all schedules and
exhibits thereto and hereto and any other documents or agreements executed in
connection with the transactions contemplated hereunder.

"Transfer Agent" means Interwest Transfer Company, Inc., the current transfer
agent of the Company, with a mailing address of 1981 Murray Holladay Road, Suite
110, Salt

5

--------------------------------------------------------------------------------

Lake City, Utah 84117 and a facsimile number of (801) 277-3147, and any
successor transfer agent of the Company.

"Unit " shall have the meaning ascribed to such term in Section 2.1.

"VIE Restructuring" shall have the meaning ascribed to such term in Section
4.18.

"Warrants " shall have the meaning ascribed to such term in Section 2.1.

ARTICLE II PURCHASE AND SALE

2.1   Closing. Upon the terms and subject to the conditions set forth herein,
the Company agrees to sell, and the Purchasers agree to purchase, severally and
not jointly, up to an aggregate of 250,000 Units at a purchase price of $28.56
per Unit, for an aggregate purchase price of up to $7,140,000 (the "Aggregate
Purchase Price"). Each "Unit" shall consist of (i) one share of a newly
designated Series A preferred stock, par value 0.001 per share ("Preferred
Stock"), with a one-to-ten conversion ratio into shares of the Company's common
stock, par value $0.001 per share ("Common Stock"), and (ii) warrants to
purchase five shares of Common Stock at an exercise price of $3.40 per share
(the "Warrants"). The shares of Preferred Stock and the Warrants being offered
and sold pursuant to this Agreement are sometimes referred to as the
"Securities." The Company and the Purchasers hereby acknowledge and agree that
the Placement Agent will receive from the Purchasers a fee equal to 2% of the
Aggregate Purchase Price, plus Warrants to purchase 2% of the aggregate number
of shares of Common Stock that shares of Preferred Stock to be issued hereunder
are convertible into, in exchange for acting as the placement agent pursuant to
the terms of the Placement Agent Agreement. Accordingly, for each Unit
purchased, $28.00 will be paid to the Company and $0.56 will be paid as
compensation to the Placement Agent, and the Company will issue to the Placement
Agent Warrants to purchase 2% of the aggregate number of shares of Common Stock
that shares of Preferred Stock to be issued hereunder are convertible into in
lieu of issuing such Warrants to the Purchasers. The number of shares of
Preferred Stock and Warrants purchased and the Purchase Price paid by each
Purchaser is set forth opposite each Purchaser's name on the signature page
attached hereto. Subject to the satisfaction or waiver of the conditions and
deliverables set forth in Sections 2.3 and 2.4, the sale of Securities being
sold hereunder shall take place pursuant to one or more closings at such times
as are mutually agreeable to the Company and ARC China (each, a "Closing", and
together, the "Closings"). At or before each Closing, each Purchaser shall
deliver to the Escrow Agent via wire transfer or a certified check of
immediately available funds equal to their Purchase Price and the Company shall
deliver to each Purchaser and/or the Escrow Agent the items set forth in Section
2.3(a) issuable at the Closing. Each Closing shall occur at the offices of the
Company Counsel or such other location as is mutually agreeable to the Company
and ARC China, and the Company and the Placement Agent shall deliver to the
Escrow Agent the Form of Escrow Release Notice (as defined in the Escrow
Agreement), duly executed.

2.2   Investor Relations and CFO Compensation Escrow. The Company acknowledges
and agrees that $350,000 of the Aggregate Purchase Price will remain in the
Escrow Account and will not be disbursed to the Company at the first Closing.
The Company further acknowledges and agrees that $100,000 (the "IR Cash") of the
$350,000 will be reserved for dissemination to investor relations firms
determined from time-to-time by ARC China in its sole discretion; provided that
such IR Cash must be disseminated on or before May 21, 2011. The remaining
$250,000 (the "CFO Compensation Cash") will be reserved as compensation for a
Chief Financial Officer candidate mutually agreeable to the Company and ARC
China; provided that such CFO Compensation Cash must be paid on or before May
21, 2012.

6

--------------------------------------------------------------------------------

2.3 Deliveries.

(a) At the Closing, the Company shall deliver or cause the following to be
delivered:

(i) to each Purchaser, this Agreement duly executed by the Company;

(ii) to each Purchaser, evidence that the Certificate of Designation has been
filed with the Secretary of State of Nevada;

(iii) to each Purchaser, legal opinions of Company Counsel and special Nevada
counsel to the Company dated as of the initial Closing Date and addressed to the
Purchasers, in forms mutually agreeable to the Company and ARC China;

(iv) to each Purchaser, a certificate evidencing a number of shares of Preferred
Stock purchased by such Purchaser set forth on such Purchaser's signature page
attached hereto;

(v) to each Purchaser, the appropriate number of Warrants issued to the
Purchaser at the Closing; and

(vi) to each Purchaser, an officer's certificate from the Chief Executive
Officer, dated as of the Closing Date, certifying and setting forth (A) the
names, signatures and positions of the Persons authorized to execute this
Agreement and any other Transaction Documents to which the Company is a party,
(B) a copy of the resolutions of the Company authorizing the execution, delivery
and performance of this Agreement, and (C) certifying that the representations
and warranties of the Company are true and correct as of the Closing Date.

(b) At the Closing, each Purchaser shall deliver or cause the following to be
delivered:

(i) to the Company, this Agreement duly executed by such Purchaser; and

(ii) to the Escrow Agent, such Purchaser's Purchase Price by wire transfer or a
certified check of immediately available funds pursuant to the instructions set
forth on Exhibit C attached hereto.

7

--------------------------------------------------------------------------------

2.4 Closing Conditions.

     (a) The obligations of the Company hereunder in connection with the Closing
are subject to the following conditions being met:

(i) the accuracy in all material respects when made and on the Closing Date of
the representations and warranties (except for representations and warranties
that speak as of a specific date, which shall be accurate in all material
respects as of such specified date) of the Purchasers contained herein;

(ii) no statute, rule, regulation, executive order, decree, ruling or injunction
shall have been enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents;

(iii) all obligations, covenants and agreements of each Purchaser required to be
performed at or prior to the Closing Date shall have been performed in all
material respects;

(iv) the delivery by each Purchaser of the items set forth in Section 2.3(b) of
this Agreement; and

(v) this Agreement shall not have been terminated as to such Purchaser in
accordance with Section 5.1.

     (b) The respective obligations of the Purchasers hereunder in connection
with the Closing are subject to the following conditions being met:

(i) the accuracy in all material respects when made and on the Closing Date of
the representations and warranties (except for representations and warranties
that speak as of a specific date, which shall be accurate in all material
respects as of such specified date) of the Company contained herein;

(ii) all obligations, covenants and agreements of the Company required to be
performed at or prior to the Closing Date shall have been performed in all
material respects;

(iii) the Certificate of Designation shall have been filed with the Secretary of
State of Nevada;

(iv) the delivery by the Company of the items set forth in Section 2.3(a) of
this Agreement;

(v) no statute, rule, regulation, executive order, decree, ruling or injunction
shall have been enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents;

8

--------------------------------------------------------------------------------

(vi) the Purchasers shall be satisfied in their sole discretion with the results
of their due diligence investigations;

(vii) there shall have been no Material Adverse Effect with respect to the
Company since the date hereof;

(viii) from the date hereof to the Closing Date, trading in the Common Stock
shall not have been suspended by the Commission or the Company's principal
Trading Market (except for any suspension of trading of limited duration agreed
to by the Company, which suspension shall be terminated prior to the Closing);
and

(ix) this Agreement shall not have been terminated as to such Purchaser in
accordance with Section 5.1.

ARTICLE III
REPRESENTATIONS AND WARRANTIES

3.1 Representations and Warranties of the Company. Except as set forth in the
Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof
and shall qualify any representation made herein to the extent of the disclosure
contained in the corresponding section of the Disclosure Schedules, the Company
hereby makes the following representations and warranties as of the date hereof
and as of the Closing Date to each Purchaser:

(a) Subsidiaries. All of the direct and indirect subsidiaries of the Company are
set forth on Schedule 3.1(a). The Company owns, directly or indirectly, all of
the capital stock or other equity interests of each Subsidiary free and clear of
any Liens, and all of the issued and outstanding shares of capital stock of each
Subsidiary are validly issued and are fully paid, non-assessable and free of
preemptive and similar rights to subscribe for or purchase securities.

(b) Organization and Qualification. The Company and each of the Subsidiaries is
an entity duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or
organization, with the requisite power and authority to own and use its
properties and assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation or default of any of the
provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the
Subsidiaries is duly qualified to conduct business and is in good standing as a
foreign corporation or other entity in each jurisdiction in which the nature of
the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in: (i) a
material adverse effect on the legality, validity or enforceability of any
Transaction Document, (ii) a material adverse effect on the results of
operations, assets, business, prospects or condition (financial or otherwise) of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company's ability to perform in any material respect on a timely
basis its obligations under any Transaction Document (any of (i), (ii) or (iii),
either individually or in the aggregate with all other effects, a "Material
Adverse Effect") and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing, or seeking to revoke, limit or curtail, such
power and authority or qualification.

9

--------------------------------------------------------------------------------

(c) Authorization; Enforcement. The Company has the requisite corporate power
and authority to enter into and to consummate the transactions contemplated by
each of the Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of each of the Transaction
Documents by the Company and the consummation by it of the transactions
contemplated hereby and thereby have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company, its Board of Directors or its stockholders in connection therewith
other than in connection with the Required Approvals. Each Transaction Document
to which it is a party has been (or upon delivery will have been) duly executed
by the Company and, when delivered in accordance with the terms hereof and
thereof, will constitute the legal, valid and binding obligation of the Company
enforceable against the Company in accordance with its terms, except: (i) as
limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting
enforcement of creditors' rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be
limited by applicable law.

(d) No Conflicts. The execution, delivery and performance by the Company of the
Transaction Documents and the consummation by the Company of the other
transactions to which it is a party and as contemplated hereby and thereby do
not and will not: (i) conflict with or violate any provision of the Company's or
any Subsidiary's certificate or articles of incorporation, bylaws or other
organizational or charter documents, (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default)
under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice, lapse of time
or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to
which the Company or any Subsidiary is a party or by which any property or asset
of the Company or any Subsidiary is bound or affected, or (iii) subject to the
Required Approvals, conflict with or result in a violation of any law, rule,
regulation, order, judgment, injunction, decree or other restriction of any
court or governmental authority to which the Company or a Subsidiary is subject
(including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in
the case of each of clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect.

(e) Filings, Consents and Approvals. The Company is not required to obtain any
consent, waiver, authorization or order of, give any notice to, or make any
filing or registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction Documents, other
than: (i) the filings required pursuant to Section 4.5, (ii) the filing with the
Commission of the Registration Statement, (iii) the notice and/or application(s)
to each applicable Trading Market for the issuance and sale and listing of the
Securities for trading thereon in the time and manner required thereby, (iv) the
filing of Form D with the Commission and such filings as are required to be made
under applicable state securities laws (collectively, the "Required Approvals");
in each case, at or prior to the Closing and (v) those that have been made or
obtained prior to the Closing.

10

--------------------------------------------------------------------------------

(f) Issuance of the Securities. The Securities are duly authorized and, when
issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company other than restrictions on transfer provided
for in the Transaction Documents.

(g) Capitalization. The capitalization of the Company is as set forth on
Schedule 3.1(g), which Schedule 3.1(g) shall also include the number of shares
of Common Stock and all series and classes of preferred stock of the Company
owned beneficially, and of record, by Affiliates of the Company as of the date
hereof. The Company has not issued any capital stock since its most recently
filed periodic report under the Exchange Act, other than pursuant to the
exercise of employee stock options under the Company's stock option plans, the
issuance of shares of Common Stock to employees pursuant to the Company's
employee stock purchase plans and pursuant to the conversion and/or exercise of
Common Stock Equivalents outstanding as of the date of the most recently filed
periodic report under the Exchange Act. No Person has any right of first
refusal, preemptive right, right of participation, extraordinary voting right,
or any similar right to participate in the transactions contemplated by the
Transaction Documents. Except as specified on Schedule 3.1(g) and as a result of
the purchase and sale of the Securities, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or
exercisable or exchangeable for, or giving any Person any right to subscribe for
or acquire any shares of Common Stock or Common Stock Equivalents, or contracts,
commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to issue additional shares of Common Stock or
Common Stock Equivalents. The issuance and sale of the Securities will not
obligate the Company to issue shares of Common Stock or other securities to any
Person (other than the Purchasers) and will not result in a right of any holder
of Company securities to adjust the exercise, conversion, exchange or reset
price under any of such securities. All of the outstanding shares of capital
stock of the Company are validly issued, fully paid and nonassessable, have been
issued in compliance with all federal and state securities laws, and none of
such outstanding shares was issued in violation of any preemptive rights or
similar rights to subscribe for or purchase securities. No further approval or
authorization of any stockholder, the Board of Directors or others is required
for the issuance and sale of the Securities. Except as specified on Schedule
3.1(g), there are no stockholders agreements, voting agreements or other similar
agreements with respect to the Company's capital stock to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company's
stockholders.

(h) SEC Reports; Financial Statements. The Company has filed all reports,
schedules, forms, statements and other documents required to be filed by the
Company under the Securities Act and the Exchange Act, including pursuant to
Section 13(a) or 15(d) thereof, for the twelve months preceding the date hereof
(or such shorter period as the Company was required by law or regulation to file
such material) (the foregoing materials, including the exhibits thereto and
documents incorporated by reference therein, being collectively referred to
herein as the "SEC Reports") on a timely basis or has received a valid extension
of such time of filing and has filed any such SEC Reports prior to the
expiration of any such extension. As of their respective dates, the SEC Reports
complied in all material respects with the requirements of the Securities Act
and the Exchange Act, as applicable, and none of the SEC Reports, when filed,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading. The financial statements of the Company included in the SEC Reports
comply in all material respects with applicable accounting requirements and the
rules and regulations of the Commission with respect thereto as in effect at the
time of filing. Such financial statements have been prepared in accordance with
GAAP, except as may be otherwise specified in such financial statements or the
notes thereto and except that unaudited financial statements may not contain all
footnotes required by GAAP, and fairly present in all material respects the
financial position of the Company and its consolidated Subsidiaries as of and
for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments.

11

--------------------------------------------------------------------------------

(i) Material Changes. Since the date of the latest audited financial statements
included within the SEC Reports, except as specifically disclosed in a
subsequent SEC Report filed prior to the date hereof: (i) there has been no
event, occurrence or development that has had or that could reasonably be
expected to result in a Material Adverse Effect, (ii) the Company has not
incurred any liabilities (contingent or otherwise) other than (A) trade
payables, accrued expenses and other liabilities incurred in the ordinary course
of business consistent with past practice and (B) liabilities not required to be
reflected in the Company's financial statements pursuant to GAAP or disclosed in
filings made with the Commission, (iii) the Company has not altered its method
of accounting, (iv) the Company has not declared or made any dividend or
distribution of cash or other property to its stockholders or purchased,
redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v) the Company has not issued any equity securities to any officer,
director or Affiliate, except pursuant to existing Company stock option plans.
The Company does not have pending before the Commission any request for
confidential treatment of information. Except for the issuance of the Securities
contemplated by this Agreement or as set forth on Schedule 3.1(i), no event,
liability or development has occurred or exists with respect to the Company or
its Subsidiaries or their respective business, properties, operations or
financial condition, that would be required to be disclosed by the Company under
applicable securities laws at the time this representation is made or deemed
made that has not been publicly disclosed at least one Trading Day prior to the
date that this representation is made.

(j) Litigation. There is no Proceeding pending or, to the knowledge of the
Company, threatened against or affecting the Company, any Subsidiary or any of
their respective properties before or by any court, arbitrator, governmental or
administrative agency or regulatory authority (federal, state, county, local or
foreign) (collectively, an "Action") which (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or
the Securities or (ii) could, if there were an unfavorable decision, have or
reasonably be expected to result in a Material Adverse Effect. Neither the
Company nor any Subsidiary, nor any director or officer thereof, is or has been
the subject of any Action involving a claim of violation of or liability under
federal or state securities laws or a claim of breach of fiduciary duty. There
has not been, and to the knowledge of the Company, there is not pending or
contemplated, any investigation by the Commission involving the Company or any
current or former director or officer of the Company. The Commission has not
issued any stop order or other order suspending the effectiveness of any
registration statement filed by the Company or any Subsidiary under the Exchange
Act or the Securities Act.

12

--------------------------------------------------------------------------------

(k) Labor Relations. No labor dispute exists or, to the knowledge of the
Company, is imminent with respect to any of the employees of the Company which
could reasonably be expected to result in a Material Adverse Effect. None of the
Company's or its Subsidiaries' employees is a member of a union that relates to
such employee's relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining
agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. No executive officer, to the knowledge of the
Company, is, or is now expected to be, in violation of any term of any
employment contract, confidentiality, disclosure or proprietary information
agreement or non-competition agreement, or any other contract or agreement or
any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of
its Subsidiaries to any liability with respect to any of the foregoing matters.
The Company and its Subsidiaries are in compliance with all U.S. federal, state,
local and foreign laws and regulations relating to employment and employment
practices, terms and conditions of employment and wages and hours, except where
the failure to be in compliance could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.

(l) Compliance. Neither the Company nor any Subsidiary: (i) is in default under
or in violation of (and no event has occurred that has not been waived that,
with notice or lapse of time or both, would result in a default by the Company
or any Subsidiary under), nor has the Company or any Subsidiary received notice
of a claim that it is in default under or that it is in violation of, any
indenture, loan or credit agreement or any other agreement or instrument to
which it is a party or by which it or any of its properties is bound (whether or
not such default or violation has been waived), (ii) is in violation of any
order of any court, arbitrator or governmental body or (iii) is or has been in
violation of any statute, rule or regulation of any governmental authority,
including without limitation all foreign, federal, state and local laws
applicable to its business and all such laws that affect the environment, except
in each case as could not have or reasonably be expected to result in a Material
Adverse Effect.

(m) Regulatory Permits. The Company and the Subsidiaries possess all
certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their
respective businesses, except where the failure to possess such permits could
not reasonably be expected to result in a Material Adverse Effect ("Material
Permits"), and neither the Company nor any Subsidiary has received any notice of
proceedings relating to the revocation or modification of any Material Permit.

(n) Title to Assets. The Company and the Subsidiaries own or have valid land use
rights to all real property that is material to their respective businesses and
good and marketable title in all personal property owned by them that is
material to the business of the Company and the Subsidiaries, in each case free
and clear of all Liens, except for Liens that do not affect the value of such
property and do not interfere with the use made and proposed to be made of such
property by the Company and the Subsidiaries and Liens for the payment of
federal, state or other taxes, the payment of which is neither delinquent nor
subject to penalties. Any real property and facilities held under lease by the
Company and the Subsidiaries are held by them under valid, subsisting and
enforceable leases with which the Company and the Subsidiaries are in
compliance.

13

--------------------------------------------------------------------------------

(o) Patents and Trademarks. The Company and the Subsidiaries have, or have
rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights,
licenses and other intellectual property rights and similar rights as described
in the SEC Reports as necessary or material for use in connection with their
respective businesses and which the failure to so have could have a Material
Adverse Effect (collectively, the "Intellectual Property Rights"). Neither the
Company nor any Subsidiary has received notice (written or otherwise) that any
of the Intellectual Property Rights used by the Company or any Subsidiary
violates or infringes upon the rights of any Person. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no
existing infringement by another Person of any of the Intellectual Property
Rights. The Company and its Subsidiaries have taken reasonable security measures
to protect the secrecy, confidentiality and value of all of their intellectual
properties, except where failure to do so could not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect.

(p) Transactions with Affiliates and Employees. Except as set forth in the SEC
Reports, none of the officers or directors of the Company and, to the knowledge
of the Company, none of the employees of the Company is presently a party to any
transaction with the Company or any Subsidiary (other than for services as
employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for
rental of real or personal property to or from, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the
Company, any entity in which any officer, director, or any such employee has a
substantial interest or is an officer, director, trustee or partner, in each
case in excess of $120,000 other than for: (i) payment of salary or consulting
fees for services rendered, (ii) reimbursement for expenses incurred on behalf
of the Company and (iii) other employee benefits, including stock option
agreements under any stock option plan of the Company.

(q) Sarbanes-Oxley; Internal Accounting Controls. The Company is in material
compliance with all provisions of the Sarbanes-Oxley Act of 2002 which are
applicable to it as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide
reasonable assurance that: (i) transactions are executed in accordance with
management's general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management's general or specific authorization, and (iv)
the recorded accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences. The Company has established disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and
designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under
the Exchange Act is recorded, processed, summarized and reported, within the
time periods specified in the Commission's rules and forms. The Company's
certifying officers have evaluated the effectiveness of the Company's disclosure
controls and procedures as of the end of the period covered by the Company's
most recently filed periodic report under the Exchange Act (such date, the
"Evaluation Date"). The Company presented in its most recently filed periodic
report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their
evaluations as of the Evaluation Date. Since the Evaluation Date, there have
been no changes in the Company's internal control over financial reporting (as
such term is defined in the Exchange Act) that has affected, or is reasonably
likely to affect, the Company's internal control over financial reporting.

14

--------------------------------------------------------------------------------

(r) Certain Fees. Except as set forth on Schedule 3.1(r), no brokerage or
finder's fees or commissions are or will be payable by the Company to any
broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by
the Transaction Documents. The Purchasers shall have no obligation with respect
to any fees or with respect to any claims made by or on behalf of other Persons
for fees of a type contemplated in this Section 3.1(r) that may be due in
connection with the transactions contemplated by the Transaction Documents.

(s) Private Placement. Assuming the accuracy of the Purchasers' representations
and warranties set forth in Section 3.2, no registration under the Securities
Act is required for the offer and sale of the Securities by the Company to the
Purchasers as contemplated hereby. The issuance and sale of the Securities
hereunder does not contravene the rules and regulations of the Trading Market.

(t) Investment Company. The Company is not, and is not an Affiliate of, and
immediately after receipt of payment for the Securities, will not be or be an
Affiliate of, an "investment company" within the meaning of the Investment
Company Act of 1940, as amended (the "Investment Company Act"). The Company
shall conduct its business in a manner so that it will not become subject to the
Investment Company Act.

(u) Registration Rights. Except as set forth on Schedule 3.1(u), other than the
registration rights of the Purchasers set forth herein, no Person has any right
to cause the Company to effect the registration under the Securities Act of any
securities of the Company.

(v) Listing and Maintenance Requirements. The Common Stock is registered
pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has
taken no action designed to, or which to the knowledge of the Company is likely
to have the effect of, terminating the registration of the Common Stock under
the Exchange Act nor has the Company received any notification that the
Commission is contemplating terminating such registration. The Company has not,
in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect
that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is, and has no reason to
believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements.

15

--------------------------------------------------------------------------------

(w) Application of Takeover Protections. The Company has not adopted any
anti-takeover provisions, and the Company and the Board of Directors have taken
all necessary action in order to render inapplicable any control share
acquisition, business combination, poison pill (including any distribution under
a rights agreement) or other similar anti-takeover provision under the Company's
articles of incorporation or the laws of its state of incorporation that is or
could become applicable to the Purchasers as a result of the Purchasers and the
Company fulfilling their obligations or exercising their rights under the
Transaction Documents, including without limitation as a result of the Company's
issuance of the Securities and the Purchasers' ownership of the Securities.

(x) Disclosure. Except with respect to the material terms and conditions of the
transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of
the Purchasers or their agents or counsel with any information that it believes
constitutes or might constitute material, nonpublic information. The Company
understands and confirms that the Purchasers will rely on the foregoing
representation in effecting transactions in securities of the Company. All
disclosure furnished by or on behalf of the Company to the Purchasers regarding
the Company, its business and the transactions contemplated hereby, including
the Disclosure Schedules to this Agreement, is true and correct and does not
contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in light of the
circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.

(y) No Integrated Offering. Assuming the accuracy of the Purchasers'
representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any security or solicited
any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company
for purposes of (i) the Securities Act which would require the registration of
any such securities under the Securities Act, or (ii) any applicable shareholder
approval provisions of any Trading Market on which any of the securities of the
Company are listed or designated. To the knowledge of the Company, all prior
sales of the Company's securities have complied with all state "blue sky" laws
and there are no rescission rights against the Company.

(z) Solvency. Based on the consolidated financial condition of the Company as of
the Closing Date before giving effect to the receipt by the Company of the
proceeds from the sale of the Securities hereunder: (i) the fair saleable value
of the Company's assets exceeds the amount that will be required to be paid on
or in respect of the Company's existing debts and other liabilities (including
known contingent liabilities) as they mature, (ii) the Company's assets do not
constitute unreasonably small capital to carry on its business as now conducted
and as proposed to be conducted including its capital needs taking into account
the particular capital requirements of the business conducted by the Company,
and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company
would receive, were it to liquidate all of its assets, after taking into account
all anticipated uses of the cash, would be sufficient to pay all amounts on or
in respect of its liabilities when such amounts are required to be paid. The
Company does not intend to incur debts beyond its ability to pay such debts as
they mature (taking into account the timing and amounts of cash to be payable on
or in respect of its debt). The Company has no knowledge of any facts or
circumstances which lead it to believe that it will file for reorganization or
liquidation under the bankruptcy or reorganization laws of any jurisdiction
within one year from the Closing Date. Schedule 3.1(z) sets forth as of the date
hereof all outstanding secured and unsecured Indebtedness of the Company or any
Subsidiary, or for which the Company or any Subsidiary has commitments. For the
purposes of this Agreement, "Indebtedness" means (x) any liabilities for
borrowed money or amounts owed in excess of $100,000 (other than trade accounts
payable incurred in the ordinary course of business), (y) all guaranties,
endorsements and other contingent obligations in respect of indebtedness of
others, whether or not the same are or should be reflected in the Company's
balance sheet (or the notes thereto), except guaranties by endorsement of
negotiable instruments for deposit or collection or similar transactions in the
ordinary course of business; and (z) the present value of any lease payments in
excess of $100,000 due under leases required to be capitalized in accordance
with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.

16

--------------------------------------------------------------------------------

(aa) Tax Status. Except for matters that would not, individually or in the
aggregate, have or reasonably be expected to result in a Material Adverse
Effect, the Company and each Subsidiary has filed all necessary federal, state
and foreign income and franchise tax returns and has paid or accrued all taxes
shown as due thereon, and to the knowledge of the Company, the Company has no
tax deficiency which has been asserted or threatened against the Company or any
Subsidiary.

(bb) No General Solicitation. Neither the Company nor any person acting on
behalf of the Company has offered or sold any of the Securities by any form of
general solicitation or general advertising. The Company has offered the
Securities for sale only to the Purchasers and certain other Accredited
Investors and non-U.S. domestic Persons.

(cc) Foreign Corrupt Practices. Neither the Company, nor to the knowledge of the
Company, any agent or other person acting on behalf of the Company, has: (i)
directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic
political activity, (ii) made any unlawful payment to foreign or domestic
government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company (or made by any person acting on its behalf of
which the Company is aware) which is in violation of law or (iv) violated in any
respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.

(dd) No Disagreements with Accountants and Lawyers. There are no disagreements
of any kind, including, but not limited to, any disagreements regarding fees
owed for services rendered, presently existing, or reasonably anticipated by the
Company to arise, between the Company and the accountants and lawyers formerly
or presently employed by the Company which could affect the Company's ability to
perform any of its obligations under any of the Transaction Documents and the
Company is current with respect to any fees owed to its accountants and lawyers.

17

--------------------------------------------------------------------------------

(ee) Acknowledgment Regarding Purchasers' Purchase of Securities. The Company
acknowledges and agrees that each of the Purchasers is acting solely in the
capacity of an arm's length purchaser with respect to the Transaction Documents
and the transactions contemplated thereby. The Company further acknowledges that
no Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to the Transaction Documents and the
transactions contemplated thereby and any advice given by any Purchaser or any
of their respective representatives or agents in connection with the Transaction
Documents and the transactions contemplated thereby is merely incidental to the
Purchasers' purchase of the Securities. The Company further represents to each
Purchaser that the Company's decision to enter into this Agreement and the other
Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.

(ff) Regulation M Compliance. The Company has not, and to the knowledge of the
Company no one acting on its behalf has, (i) taken, directly or indirectly, any
action designed to cause or to result in the stabilization or manipulation of
the price of any security of the Company to facilitate the sale or resale of any
of the Securities, (ii) sold, bid for, purchased, or paid any compensation for
soliciting purchases of, any of the securities of the Company, or (iii) paid or
agreed to pay to any Person any compensation for soliciting another to purchase
any other securities of the Company, other than, in the case of clauses (ii) and
(iii), compensation paid to the Company's placement agent in connection with the
placement of the Securities.

(gg) Obligations of Management. Each officer and key employee of the Company and
its Subsidiaries is currently devoting substantially all of his or her business
time to the conduct of business of the Company and its Subsidiaries. Neither the
Company nor any of its Subsidiaries is aware that any officer or key employee of
the Company or any Subsidiary is planning to work less than full time at the
Company or any Subsidiary, as applicable, in the future. No officer or key
employee is currently working or, to the knowledge of the Company, plans to work
for a competitive enterprise, whether or not such officer of key employee is or
will be compensated by such enterprise.

(hh) Employee Benefits. Except as set forth on Schedule 3.1(hh), neither the
Company nor any Subsidiary has (nor for the two years preceding the date hereof
has had) any plans which are subject to ERISA. "ERISA" means the Employee
Retirement Income Security Act of 1974 or any successor law and the regulations
and rules issued pursuant to that act or any successor law.

(ii) Exclusivity. Except as set forth on Schedule 3.1(ii), the Company is not a
party to any exclusivity agreement or arrangement, written, oral or otherwise
memorialized, and the Company is not in violation of any such exclusivity
agreement or arrangement.

(jj) Shareholder Rights Plan. The Company has not adopted any plan or
arrangement under which the Company or any other Person can claim that any
Purchaser is an "acquiring person" under any control share acquisition, business
combination, poison pill (including any distribution under a rights agreement)
or similar anti-takeover plan or that any Purchaser could be deemed to trigger
the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between
the Company and the Purchaser.

18

--------------------------------------------------------------------------------

3.2 Representations and Warranties of the Purchasers. Each Purchaser, for itself
and for no other Purchaser, hereby represents and warrants as of the date hereof
and as of the Closing Date to the Company as follows:

(a) Organization; Authority. If such Purchaser is a business entity, such
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization, if applicable, with full
right, corporate or partnership power and authority to enter into and to
consummate the transactions contemplated by the Transaction Documents to which
it is a party and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of the Transaction Documents to which it
is a party and performance by such Purchaser of the transactions contemplated by
the Transaction Documents to which it is a party have been duly authorized by
all necessary corporate action on the part of such Purchaser or, if such
Purchaser is not a corporation, such partnership, limited liability company or
other applicable like action, on the part of such Purchaser. Each Transaction
Document to which it is a party has been duly executed by such Purchaser, and
when delivered by such Purchaser in accordance with the terms hereof, will
constitute the legal, valid and binding obligation of such Purchaser,
enforceable against it in accordance with its terms, except: (i) as limited by
general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting
enforcement of creditors' rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be
limited by applicable law.

(b) Investment Representation. Such Purchaser is purchasing the Securities for
its own account for investment and not with a view to distribute or sell in
violation of the Securities Act or any state securities laws or rules and
regulations promulgated thereunder. Such Purchaser has been advised and
understands that the Securities have not been registered under the Securities
Act or under the "blue sky" laws of any jurisdiction and may be resold only if
registered pursuant to the provisions of the Securities Act or if an exemption
from registration is available, except under circumstances where neither such
registration nor such an exemption is required by law. Such Purchaser is
acquiring the Securities hereunder in the ordinary course of its business.
Except as set forth on Schedule 3.2(b), such Purchaser does not have any
agreement or understanding, directly or indirectly, with any Person to
distribute any of the Securities.

(c) Purchaser Status. At the time such Purchaser was offered the Securities, it
was, and as of the date hereof it is, an Accredited Investor, and has initialed
the category of Accredited Investor applicable to the Purchaser on the Purchaser
signature page attached hereto; provided, that if a Purchaser is not a U.S.
domestic Person, such Purchaser shall initial the category for foreign investors
on the Purchaser signature page attached hereto. Such Purchaser is not required
to be registered as a broker-dealer under Section 15 of the Exchange Act, and is
not affiliated with any broker-dealer registered under Section 15 of the
Exchange Act.

19

--------------------------------------------------------------------------------

(d) Experience of Such Purchaser. Such Purchaser, either alone or together with
its representatives (who satisfy all of the affiliation, financial experience,
acknowledgment and disclosure conditions set forth under Rule 501(h) of
Regulation D), has such knowledge, sophistication and experience in business and
financial matters so as to be capable of evaluating the merits and risks of the
prospective investment in the Securities, and has so evaluated the merits and
risks of such investment. Such Purchaser is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a
complete loss of such investment.

(e) General Solicitation. Such Purchaser is not purchasing the Securities as a
result of any advertisement, article, notice or other communication regarding
the Securities published in any newspaper, magazine or similar media or
broadcast over television or radio or presented at any seminar or any other
general solicitation or general advertisement.

(f) Access to Information. Such Purchaser acknowledges that it has reviewed the
SEC Reports and the Disclosure Schedules (collectively, the “Disclosure
Materials”) and has been afforded (i) the opportunity to ask such questions as
it has deemed necessary of, and to receive answers from, representatives of the
Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to
information about the Company and the Subsidiaries and their respective
financial condition, results of operations, business, properties, management and
prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or
can acquire without unreasonable effort or expense that is necessary to make an
informed investment decision with respect to the investment. Neither such
inquiries nor any other investigation conducted by or on behalf of such
Purchaser or its representatives or counsel shall modify, amend or affect such
Purchaser’s right to rely on the truth, accuracy and completeness of the
Disclosure Materials and the Company’s representations and warranties contained
in the Transaction Documents.

(g) Certain Trading Activities. Such Purchaser has not directly or indirectly,
nor has any Person acting on behalf of or pursuant to any understanding with
such Purchaser, engaged in any transactions in the securities of the Company
(including, without limitations, any Short Sales involving the Company’s
securities) since the earlier to occur of (1) the time that such Purchaser was
first contacted by the Company, the Placement Agent, or any other Person acting
on behalf of the Company regarding an investment in the Company and (2) the 30th
day prior to the date of this Agreement. Such Purchaser covenants that neither
it nor any Person acting on its behalf or pursuant to any understanding with it
will engage in any transactions in the securities of the Company (including
Short Sales) prior to the time that the transactions contemplated by this
Agreement are publicly disclosed.

(h) Independent Investment Decision. Such Purchaser has independently evaluated
the merits of its decision to purchase the Securities pursuant to the
Transaction Documents, and such Purchaser confirms that it has not relied on the
advice of any other Purchaser’s business and/or legal counsel in making such
decision. Such Purchaser has not relied on the business or legal advice of the
Placement Agent or any of its agents, counsel or Affiliates in making its
investment decision hereunder, and confirms that none of such Persons has made
any representations or warranties to such Purchaser in connection with the
transactions contemplated by the Transaction Documents.

20

--------------------------------------------------------------------------------

(i) Reliance on Exemptions. The Purchaser understands that the Securities are
being offered and sold to it in reliance upon specific exemptions from the
registration requirements of United States federal and state securities laws and
that the Company is relying upon the truth and accuracy of, and the Purchaser’s
compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire
the Securities. All of the information which the Purchaser has provided to the
Company is true, correct and complete as of the date this Agreement is signed,
and if there should be any change in such information prior to the Closing, the
Purchaser will immediately provide the Company with such information.

(j) Regulation S. If such Purchaser is not a U.S. Person (as such term is
defined in Section 902(a) of Regulation S), such Purchaser (i) acknowledges that
the certificate(s) representing or evidencing the Securities contain a customary
restrictive legend restricting the offer, sale or transfer of any Securities
except in accordance with the provisions of Regulation S, pursuant to
registration under the Securities Act, or pursuant to an available exemption
from registration, (ii) agrees that all offers and sales by such Purchaser of
Securities shall be made pursuant to an effective registration statement under
the Securities Act or pursuant to an exemption from, or a transaction not
subject to the registration requirements of, the Securities Act, (iii)
represents that the offer to purchase the Securities was made to such Purchaser
outside of the United States, and such Purchaser was, at the time of the offer
and will be, at the time of the sale and is now, outside the United States, (iv)
has not engaged in or directed any unsolicited offers to purchase Securities in
the United States, (v) is neither a U.S. Person nor a Distributor (as such terms
are defined in Section 902(a) and 902(c), respectively, of Regulation S), (vi)
has purchased the Securities for its own account and not for the account or
benefit of any U.S. Person, (vii) is the sole beneficial owner of the Securities
specified on the Purchaser signature page attached hereto opposite his name and
has not pre-arranged any sale with a Purchaser in the United States, and (ix) is
familiar with and understands the terms and conditions and requirements
contained in Regulation S, specifically, without limitation, each Purchaser
understands that the statutory basis for the exemption claimed for the sale of
the Securities would not be present if the sale, although in technical
compliance with Regulation S, is part of a plan or scheme to evade the
registration provisions of the Securities Act.

(k) No Government Review. Such Purchaser understands that no United States
federal or state agency or any other government or governmental agency has
passed on or made any recommendation or endorsement of the Securities or the
fairness or suitability of the investment in the Securities nor have such
authorities passed upon or endorsed the merits thereof.

(l) Correctness of Representations and Information. Such Purchaser represents
that the representations and warranties of this Section 3.2 and the information
provided by such Purchaser on the signature page hereof are true and correct as
of the date hereof and, unless such Purchaser otherwise notifies the Company
prior to the Closing Date, shall be true and correct as of the Closing Date.

21

--------------------------------------------------------------------------------

ARTICLE IV
OTHER AGREEMENTS OF THE PARTIES

4.1 Transfer Restrictions.

(a) The Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement, to the Company, to an Affiliate
of a Purchase or in connection with a pledge as contemplated in Section 4.1(b),
the Company may require the transferor thereof to provide to the Company an
opinion of counsel selected by the transferor, the form and substance of which
opinion shall be reasonably satisfactory to the Company, to the effect that such
transfer does not require registration of such transferred Securities under the
Securities Act.

(b) The Purchasers agree to the imprinting, in addition to the legend described
in Section 3.2(j) as the case may be, so long as is required by this Section
4.1, of a legend on any of the Securities in the following form:

THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES
HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

The Company acknowledges and agrees that a Purchaser may from time to time
pledge pursuant to a bona fide margin agreement with a registered broker-dealer
or grant a security interest in some or all of the Securities to a financial
institution that is an Accredited Investor as defined in Rule 501(a) of the
Securities Act and who agrees to be bound by the provisions of this Agreement
and, if required under the terms of such arrangement, such Purchaser may
transfer pledged or secured Securities to the pledgees or secured parties. Such
a pledge or transfer would not be subject to approval of the Company and no
legal opinion of legal counsel of the pledgee, secured party or pledgor shall be
required in connection therewith. Further, no notice shall be required of such
pledge. At the appropriate Purchaser's expense, the Company will execute and
deliver such reasonable documentation as a pledgee or secured party of
Securities may reasonably request in connection with a pledge or transfer of the
Securities, including, if the Securities are subject to registration pursuant
Section 4.17 hereof, the preparation and filing of any required prospectus
supplement under Rule 424(b)(3) under the Securities Act or other applicable
provision of the Securities Act to appropriately amend the list of selling
stockholders thereunder. Except as otherwise provided in Section 4.1(c), any
Securities subject to a pledge or security interest as contemplated by this
Section 4.1(b) shall continue to bear the legend set forth in this Section
4.1(b) and be subject to the restrictions on transfer set forth in Section
4.1(a) .

22

--------------------------------------------------------------------------------

(c) Certificates evidencing the Common Stock shall not contain any legend
(including the legend set forth in Section 4.1(b) hereof): (i) while a
registration statement (including the Registration Statement) covering the
resale of such security is effective under the Securities Act, (ii) following
any sale of such Common Stock pursuant to Rule 144 or (iii) if such legend is
not required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the
Commission). The Company shall cause its counsel to issue a legal opinion to the
Transfer Agent promptly after the Effective Date if required by the Transfer
Agent to effect the removal of the legend hereunder. The Company agrees that
following the Effective Date or at such time as such legend is no longer
required under this Section 4.1(c), the Company will, no later than five Trading
Days following the delivery by a Purchaser to the Company or the Transfer Agent
of a certificate representing Common Stock, as applicable, issued with a
restrictive legend, deliver or cause to be delivered to such Purchaser a
certificate representing such shares that is free from all restrictive and other
legends. The Company may not make any notation on its records or give
instructions to the Transfer Agent that enlarge the restrictions on transfer set
forth in this Section 4. If the Company is then eligible, certificates for
shares of Common Stock subject to legend removal hereunder shall be transmitted
by the Transfer Agent to the Purchaser by crediting the account of the
Purchaser's prime broker with the Depository Trust Company System as directed by
such Purchaser.

(d) Each Purchaser, severally and not jointly with the other Purchasers, agrees
that such Purchaser will sell Securities pursuant to either the registration
requirements of the Securities Act, including any applicable prospectus delivery
requirements, or an exemption therefrom, and that if Securities are sold
pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the
restrictive legend from certificates representing the Securities as set forth in
this Section 4.1 is predicated upon the Company's reliance upon this
understanding.

4.2 Acknowledgment of Dilution. The Company acknowledges that the issuance of
the Securities may result in dilution of the outstanding shares of Common Stock,
which dilution may be substantial under certain market conditions. The Company
further acknowledges that its obligations under the Transaction Documents are
unconditional and absolute and not subject to any right of set off,
counterclaim, delay or reduction, regardless of the effect of any such dilution
or any claim the Company may have against any Purchaser and regardless of the
dilutive effect that such issuance may have on the ownership of the other
stockholders of the Company.

4.3 Furnishing of Information. Until such time that no Purchaser owns any
Securities, the Company covenants to maintain the registration of the Securities
under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain
extensions in respect thereof and file within the applicable grace period) all
reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act. As long as any Purchaser owns Securities, if the Company is
not required to file reports pursuant to the Exchange Act, it will prepare and
furnish to the Purchasers and make publicly available in accordance with Rule
144(c) such information as is required for the Purchasers to sell the Securities
under Rule 144. The Company further covenants that it will take such further
action as any holder of Securities may reasonably request, to the extent
required from time to time to enable such Person to sell such Securities without
registration under the Securities Act within the requirements of the exemption
provided by Rule 144.

23

--------------------------------------------------------------------------------

4.4 Integration. The Company shall not sell, offer for sale or solicit offers to
buy or otherwise negotiate in respect of any security (as defined in Section 2
of the Securities Act) that would be integrated with the offer or sale of the
Securities to the Purchasers in a manner that would require the registration
under the Securities Act of the sale of the Securities to the Purchasers or that
would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market.

4.5 Securities Laws Disclosure; Publicity. The Company shall by 5:30 p.m. (New
York time) on the fourth Trading Day following the execution of this Agreement,
file a Current Report on Form 8-K, disclosing the material terms of the
Agreement and the transactions contemplated hereby and thereby and including the
Transaction Documents as exhibits thereto as required by the Commission. On the
fourth Trading Day following any Closing Date, the Company will file an
additional Current Report on Form 8-K to disclose such Closing.

4.6 Shareholder Rights Plan. No claim will be made or enforced by the Company
or, with the consent of the Company, any other Person, that any Purchaser is an
"acquiring person" under any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement) or similar
anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Purchaser could be deemed to trigger the provisions of any such plan
or arrangement, by virtue of receiving Securities under the Transaction
Documents or under any other agreement between the Company and the Purchasers.

4.7 Non-Public Information. Except with respect to the material terms and
conditions of the transactions contemplated by the Transaction Documents, the
Company covenants and agrees that neither it, nor any other Person acting on its
behalf, will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
prior thereto such Purchaser shall have executed a written agreement regarding
the confidentiality and use of such information. The Company understands and
confirms that each Purchaser shall be relying on the foregoing covenant in
effecting transactions in securities of the Company.

4.8 Use of Proceeds. The Company shall use the net proceeds from the sale of the
Securities hereunder for working capital purposes and shall not use such
proceeds for: (a) the satisfaction of any portion of the Company's debt (other
than payment of trade payables in the ordinary course of the Company's business
and prior practices), (b) the redemption of any Common Stock or Common Stock
Equivalents or (c) the settlement of any outstanding litigation.

24

--------------------------------------------------------------------------------

4.9 Indemnification of Purchasers. Subject to the provisions of this Section
4.9, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees, agents, successors and
permitted assigns (and any other Persons with a functionally equivalent role of
a Person holding such titles notwithstanding a lack of such title or any other
title), each Person who controls such Purchaser (within the meaning of Section
15 of the Securities Act and Section 20 of the Exchange Act), and the directors,
officers, shareholders, agents, members, partners or employees (and any other
Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title) of such controlling
person (each, a "Purchaser Party") harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses,
including all judgments, amounts paid in settlements, court costs and reasonable
attorneys' fees and costs of investigation that any such Purchaser Party may
suffer or incur as a result of or relating to (a) any breach of any of the
representations, warranties, covenants or agreements made by the Company in this
Agreement or in the other Transaction Documents or (b) any action instituted
against a Purchaser in any capacity, or any of them or their respective
Affiliates, by any stockholder of the Company who is not an Affiliate of such
Purchaser, with respect to any of the transactions contemplated by the
Transaction Documents (unless such action is based upon a breach of such
Purchaser's representations, warranties or covenants under the Transaction
Documents to which it is a party or any agreements or understandings such
Purchaser may have with any such stockholder or any violations by the Purchaser
of state or federal securities laws or any conduct by such Purchaser which
constitutes fraud, gross negligence, willful misconduct or malfeasance). If any
action shall be brought against any Purchaser Party in respect of which
indemnity may be sought pursuant to this Agreement, such Purchaser Party shall
promptly notify the Company in writing, and the Company shall have the right to
assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to
employ separate counsel in any such action and participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of
such Purchaser Party except to the extent that (i) the employment thereof has
been specifically authorized by the Company in writing, (ii) the Company has
failed after a reasonable period of time to assume such defense and to employ
counsel or (iii) in such action there is, in the reasonable opinion of such
separate counsel, a material conflict on any material issue between the position
of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more
than one such separate counsel. The Company will not be liable to any Purchaser
Party under this Agreement (y) for any settlement by a Purchaser Party effected
without the Company's prior written consent, which shall not be unreasonably
withheld or delayed; or (z) to the extent, but only to the extent that a loss,
claim, damage or liability is attributable to any Purchaser Party's breach of
any of the representations, warranties, covenants or agreements made by such
Purchaser Party in this Agreement or in the other Transaction Documents to which
it is a party or from such Purchaser Party's fraud, gross negligence, willful
misconduct or malfeasance.

4.10 Reservation and Listing of Securities. The Company shall maintain a reserve
from its duly authorized shares of Common Stock and Preferred Stock for issuance
pursuant to the Transaction Documents in such amount as may then be required to
fulfill its obligations in full under the Transaction Documents.

25

--------------------------------------------------------------------------------

4.11 Equal Treatment of Purchasers. No consideration (including any modification
of any Transaction Document) shall be offered or paid to any Person to amend or
consent to a waiver or modification of any provision of any of the Transaction
Documents unless the same consideration is also offered to all of the parties to
the applicable Transaction Documents. For clarification purposes, this provision
constitutes a separate right granted to each Purchaser by the Company and
negotiated separately by each Purchaser, and is intended for the Company to
treat the Purchasers as a class and shall not in any way be construed as the
Purchasers acting in concert or as a group with respect to the purchase,
disposition or voting of Securities or otherwise.

4.12 Form D; Blue Sky Filings. The Company agrees to timely file a Form D with
respect to the Securities as required under Regulation D and provide copies
thereof, promptly upon request of any Purchaser. The Company shall take such
action as the Company shall reasonably determine is necessary in order to obtain
an exemption for, or to qualify the Securities for, sale to the Purchasers at
the Closing under applicable securities or "Blue Sky" laws of the states of the
United States, and shall provide evidence of such actions promptly upon request
of any Purchaser.

4.13 Appointment of Chief Financial Officer. Within 60 calendar days of the
Closing Date, the Company shall appoint a bilingual (English and Chinese) Chief
Financial Officer who is mutually agreeable to the Company and ARC China and is
qualified to hold such position in a publicly traded company (the “Qualified
CFO”). Upon such appointment, the Company will grant to the Qualified CFO
100,000 shares of restricted Common Stock under the Company’s 2009 Equity
Incentive Plan (the “CFO Restricted Shares”). Such CFO Restricted Shares grant
shall be evidenced by a restricted shares grant agreement to be entered into
between the Company and the Qualified CFO and the CFO Restricted Shares will be
subject to the terms and conditions set forth therein.

4.14 Senior Exchange Listing. The Company shall use its best efforts to cause
the Common Stock to be eligible for listing on the Nasdaq Capital Market or the
NYSE Amex.

4.15 Board Designee; Independent Board of Directors; Board Committees. The
Company shall cause one person designated by ARC China to be duly appointed or
elected to the Company's Board of Directors. The Company shall add members to
its Board of Directors such that within 60 calendar days from the Closing Date
(i) a majority of the Board of Directors shall be "independent directors" within
the meaning of the rules of the Nasdaq Stock Market and/or the NYSE Amex, and
(ii) the Board of Directors will have established an audit committee,
compensation committee and nominating committee.

4.16 Investor Presentations; Investor Relations. So long as any Purchaser holds
Securities, the Company shall conduct at least four investor presentations
during each 12-month period following the Closing Date in each of the U.S. and
Europe. The Company covenants and agrees that it will engage one or more
investor relations firms mutually agreeable to the Company and ARC China, which,
in exchange for investor relations services rendered for the Company, such
investor relations firms will receive the IR Cash described in Section 2.2 and
at such times as mutually agreeable to the Company and ARC China.

26

--------------------------------------------------------------------------------

4.17 Registration Rights.

(a) "Mandatory Registration"

(i) No later than 30 days following the Company's receipt of a written request
from the Required Holders after the Closing Date (the "Required Filing Date"),
the Company shall use its commercially reasonable efforts to file a Registration
Statement on Form S-1 (or any similar or successor forms promulgated by the
Commission) to register the Common Stock underlying the Securities held by the
Purchasers (the "Registrable Securities") (the actual date of such filing, the
"Filing Date"), and use its commercially reasonable efforts to cause the
Registration Statement to be declared effective by the date (the "Required
Effective Date") which is not later than the earlier of (x) 150 calendar days
after the Required Filing Date, or (y) if the Registration Statement is not
reviewed by the Commission, five Business Days after oral or written notice to
the Company or its counsel from the Commission that there will not be a review;

(ii) Notwithstanding anything to the contrary contained in this Section 4.17, if
the Company receives Commission Comments, and following discussions with and
responses to the Commission in which the Company uses its commercially
reasonable best efforts and time to cause as many Registrable Securities for as
many Purchasers as possible to be included in the Registration Statement filed
pursuant to Section 4.17(a)(i) without characterizing any Purchaser as an
underwriter unless such characterization is consistent with written information
provided by the Purchaser in the Selling Holder Questionnaire (as defined below)
(and in such regard uses its commercially reasonable best efforts to cause the
Commission to permit the Placement Agent or its counsel to participate in
Commission conversations on such issue together with the Company’s counsel, and
timely conveys relevant information concerning such issue with the Placement
Agent or its counsel) (the day that such discussions and responses are concluded
shall be referred to as the “Tolling Date”), the Company is unable to cause the
inclusion of all Registrable Securities, then the Company may, following not
less than three (3) Trading Days prior written notice to the Placement Agent (i)
remove from the Registration Statement such Registrable Securities (the “Cut
Back Shares”) and/or (ii) agree to such restrictions and limitations on the
registration and resale of the Registrable Securities, in each case as the
Commission may require in order for the Commission to allow such Registration
Statement to become effective; provided, that in no event may the Company
characterize any Purchaser as an underwriter unless such characterization is
consistent with written information provided by the Purchaser in the Selling
Holder Questionnaire (collectively, the “SEC Restrictions”). Unless the SEC
Restrictions otherwise require, any cut-back imposed pursuant to this Section
4.17(a)(ii) shall be allocated among the Registrable Securities of the
Purchasers on a pro rata basis. No liquidated damages under Section 4.17(a)(vii)
shall accrue on or as to any Cut Back Shares, and the Required Effective Date
for such Registration Statement will be tolled until such time as the Company is
able to effect the registration of the Cut Back Shares in accordance with any
SEC Restrictions if such Registrable Securities cannot at such time be resold by
the Purchasers thereof without volume limitations pursuant to Rule 144 (such
date, the “Restriction Termination Date”). From and after the Restriction
Termination Date, all provisions of this Section 4.17 shall again be applicable
to the Cut Back Shares (which, for avoidance of doubt, retain their character as
“Registrable Securities”) if such Registrable Securities cannot at such time be
resold by the Purchasers thereof without volume limitations pursuant to Rule 144
so that the Company will be required to file with and cause to be declared
effective by the Commission such additional Registration Statements in the time
frames set forth herein as necessary to ultimately cause to be covered by
effective Registration Statements all Registrable Securities. For the avoidance
of doubt, the time period starting from the Tolling Date and ending with the
Restriction Termination Date shall be excluded in calculating the applicable
Effective Date.

27

--------------------------------------------------------------------------------

(iii) the Company will pay all expenses associated with the registration,
including, without limitation, filing and printing fees, and the Company's
counsel and accounting fees and expenses, costs, if any, associated with
clearing the Registrable Securities for sale under applicable state securities
laws;

(iv) Notwithstanding anything to the contrary contained in this Section 4.17,
the Company shall have the right to delay, including, without limitation, by
delaying the filing or effectiveness of the Registration Statement, the
disclosure of material, non-public information concerning the Company the
disclosure of which at the time is not, in the reasonable opinion of the Company
in the best interest of the Company and, as applicable, suspend sales of
Registrable Securities under an effective registration statement or suspend
trading of its securities on any exchange;

(v) the Company will use commercially reasonable efforts to cause the
Registration Statement to remain continuously effective for a period (the
"Effectiveness Period") that will terminate upon the earlier of (x) the second
anniversary of the Required Effective Date, (y) the date on which all the
Registrable Securities covered by the Registration Statement have been sold or
(z) the date on which all the Registrable Securities covered by the Registration
Statement may be sold immediately without registration under the Securities Act
and without volume restrictions pursuant to Rule 144(b), as determined by
reputable United States securities counsel to the Company pursuant to a written
opinion letter to such effect, addressed and acceptable to the Transfer Agent
and the affected Purchasers, and will advise the Purchasers when the
Effectiveness Period has expired with respect to the Purchasers; and

(vi) If (A) the Registration Statement is not filed on or before the Required
Filing Date, (B) the Registration Statement is not declared effective on or
before the Required Effective Date, or (C) the Registration Statement is
declared effective but shall thereafter cease to be effective for a period of
time which shall exceed 25 days in the aggregate per year (defined as a period
of 365 days commencing on the date the Registration Statement is declared
effective) or more than 15 consecutive days at any one time (each such event
referred to in clauses A through C of this Section 4.17(a)(vi), a
"Non-Registration Event"), then the Company shall deliver to the holder of
Registrable Securities, as liquidated damages ("Liquidated Damages"), an amount
in cash equal to 1% of the aggregate Purchase Price of the Securities owned of
record by such holder and an additional 1% of the aggregate Purchase Price of
the Securities owned of record by such holder for each subsequent 30-day period
(pro rata for any period less than 30 days) which are subject to such
Non-Registration Event, but in no event shall Liquidated Damages exceed 8% of
the Purchase Price. The Liquidated Damages must be paid on the first Business
Day immediately following the Non-Registration Event and on each 30th day
thereafter or shorter part thereof for which Liquidated Damages are payable.
Notwithstanding the foregoing, the Company shall not be liable to any Purchaser
under this Section 4.17(a)(vi) for any events or delays occurring as a
consequence of the acts or omissions of such Purchaser contrary to the
obligations undertaken by the Purchasers in this Agreement.

28

--------------------------------------------------------------------------------

(b) Purchaser Information. Each Purchaser shall (A) furnish to the Company a
completed Questionnaire in the form attached to this Agreement as Exhibit D (a
“Selling Holder Questionnaire”). The Company shall not be required to include
the Registrable Securities of a Purchaser in a Registration Statement and shall
not be required to pay any liquidated or other damages under Section 4.17(a)(vi)
to any Purchaser who fails to furnish to the Company a fully completed Selling
Holder Questionnaire at least three Trading Days prior to the Required Filing
Date and (B) immediately discontinue disposition of Registrable Securities
pursuant to any registration statement upon notice from the Company of (x) the
issuance of any stop order or other suspension of effectiveness of the
Registration Statement by the Commission, or the suspension of the qualification
of any of the Registrable Securities for sale in any jurisdiction by the
applicable regulatory authorities or (y) the happening of any event, as promptly
as practicable after becoming aware of such event, as a result of which the
prospectus included in the Registration Statement, as then in effect, includes
an untrue statement of a material fact or omission to state a material fact
required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading or (z) the
failure of the prospectus included in the Registration Statement, as then in
effect, to comply with the requirements of the Securities Act until the
Purchaser's receipt of a supplemented or amended prospectus or receipt of notice
that no supplement or amendment is required.

(c) Indemnification and Contribution.

(i) In the event of a registration of any Registrable Securities under the
Securities Act pursuant to this Section 4.17, the Company will, to the extent
permitted by law, indemnify and hold harmless each Purchaser, its officers,
directors and other person, if any, who controls such Purchaser within the
meaning of the Securities Act, against any losses, claims, damages or
liabilities, joint or several, to which such Purchaser or such controlling
person may become subject under the Securities Act or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out
of or are based upon any untrue statement or alleged untrue statement of any
material fact contained in the Registration Statement, any preliminary
prospectus or final prospectus contained therein, or any amendment or supplement
thereof, or arise out of or are based upon the omission or alleged omission to
state therein a material fact required to be stated therein or necessary to make
the statements therein not misleading in light of the circumstances when made,
and will subject to the provisions of Section 4.17(c)(iii) reimburse such
Purchaser and each such controlling person for any legal or other expenses
reasonably incurred by them in connection with investigating or defending any
such loss, claim, damage, liability or action; provided, however, that the
Company shall not be liable to such Purchaser or any such controlling person to
the extent that any such damages arise out of or are based upon an untrue
statement or omission made in any preliminary prospectus if (i) such Purchaser
failed to send or deliver a copy of the final prospectus delivered by the
Company to such Purchaser with or prior to the delivery of written confirmation
of the sale by such Purchaser to the person asserting the claim from which such
damages arise, (ii) the final prospectus would have corrected such untrue
statement or alleged untrue statement or such omission or alleged omission, or
(iii) to the extent that any such loss, claim, damage or liability arises out of
or is based upon an untrue statement or alleged untrue statement or omission or
alleged omission so made in conformity with information furnished by any
Purchaser or any controlling person in writing specifically for use in the
Registration Statement or prospectus.

29

--------------------------------------------------------------------------------

(ii) In the event of a registration of any of the Registrable Securities under
the Securities Act pursuant to this Section 4.17, each Purchaser severally but
not jointly will, to the extent permitted by law, indemnify and hold harmless
the Company, and each person, if any, who controls the Company within the
meaning of the Securities Act, each officer of the Company who signs the
Registration Statement, and each director of the Company, against all losses,
claims, damages or liabilities, joint or several, to which the Company or such
officer, director or controlling person may become subject under the Securities
Act or otherwise, insofar as such losses, claims, damages or liabilities (or
actions in respect thereof) arise out of or are based upon any untrue statement
or alleged untrue statement of any material fact contained in the Registration
Statement, any preliminary prospectus or final prospectus contained therein, or
any amendment or supplement thereof, or arise out of or are based upon the
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, and
will reimburse the Company and each such officer, director and controlling
person for any legal or other expenses reasonably incurred by them in connection
with investigating or defending any such loss, claim, damage, liability or
action, provided, however, that such Purchaser will be liable hereunder in any
such case if and only to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or alleged untrue
statement or omission or alleged omission made in reliance upon and in
conformity with information pertaining to such Purchaser, as such, furnished in
writing to the Company by such Purchaser specifically for use in the
Registration Statement or prospectus, and provided, further, however, that the
liability of such Purchaser hereunder shall be limited to the net proceeds
actually received by such Purchaser from the sale of Registrable Securities
covered by the Registration Statement.

(iii) Promptly after receipt by an indemnified party hereunder of notice of the
commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against the indemnifying party hereunder, notify the
indemnifying party in writing thereof, but the omission so to notify the
indemnifying party shall not relieve it from any liability which it may have to
such indemnified party other than under this Section 4.17(c)(iii) and shall only
relieve it from any liability which it may have to such indemnified party under
this Section 4.17(c)(iii), except and only if and to the extent the indemnifying
party is prejudiced by such omission. In case any such action shall be brought
against any indemnified party and it shall notify the indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate in
and, to the extent it shall wish, to assume and undertake the defense thereof
with counsel satisfactory to such indemnified party, and, after notice from the
indemnifying party to such indemnified party of its election so to assume and
undertake the defense thereof, the indemnifying party shall not be liable to
such indemnified party under this Section 4.17(c)(iii) for any legal expenses
subsequently incurred by such indemnified party in connection with the defense
thereof other than reasonable costs of investigation and of liaison with counsel
so selected, provided, however, that, if the defendants in any such action
include both the indemnified party and the indemnifying party and the
indemnified party shall have reasonably concluded that there may be reasonable
defenses available to it which are different from or additional to those
available to the indemnifying party or if the interests of the indemnified party
reasonably may be deemed to conflict with the interests of the indemnifying
party, the indemnified parties, as a group, shall have the right to select one
separate counsel and to assume such legal defenses and otherwise to participate
in the defense of such action, with the reasonable expenses and fees of such
separate counsel and other expenses related to such participation to be
reimbursed by the indemnifying party as incurred.

30

--------------------------------------------------------------------------------

(iv) In order to provide for just and equitable contribution in the event of
joint liability under the Securities Act in any case in which either (i) a
Purchaser, or any controlling person of a Purchaser, makes a claim for
indemnification pursuant to this Section 4.17(c) but it is judicially determined
(by the entry of a final judgment or decree by a court of competent jurisdiction
and the expiration of time to appeal or the denial of the last right of appeal)
that such indemnification may not be enforced in such case notwithstanding the
fact that this Section 4.17(c) provides for indemnification in such case, or
(ii) contribution under the Securities Act may be required on the part of such
Purchaser or such controlling person in circumstances for which indemnification
is not provided under this Section 4.17(c); then, and in each such case, the
Company and such Purchaser will contribute to the aggregate losses, claims,
damages or liabilities to which they may be subject (after contribution from
others) in such proportion so that such Purchaser is responsible only for the
portion represented by the percentage that the public offering price of its
securities offered by the registration statement bears to the public offering
price of all securities offered by such registration statement, provided,
however, that, in any such case, (y) such Purchaser will not be required to
contribute any amount in excess of the public offering price of all such
securities sold by it pursuant to such registration statement; and (z) no person
or entity guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) will be entitled to contribution from any person or
entity who was not guilty of such fraudulent misrepresentation.

4.18 VIE Restructuring. The Company agrees and covenants that within four months
after the Closing Date, the Company will reorganize its structural relationship
with its Chinese onshore operating company into a "Variable Interest Entity"
structure (the "VIE Restructuring"). The Company further agrees and covenants
that it will not transfer or disburse Closing proceeds to the Chinese onshore
operating company or any other Person in China unless and until the VIE
Restructuring has been completed.

ARTICLE V
MISCELLANEOUS

5.1 Termination. This Agreement may be terminated prior to Closing: (i) by
written agreement of the Placement Agent and the Company, a copy of which shall
be provided to the Escrow Agent; (ii) by a Purchaser (as to itself but not other
Purchaser), if the Company's Closing conditions set forth in Section 2.4(b) have
not been satisfied or waived by such Purchaser on or before June 11, 2010;
provided, that the right to terminate this Agreement under this Section 5.1(ii)
shall not be available to such Purchaser whose failure to comply with its
obligations under this Agreement has been the cause of or resulted in the
failure of the Closing to occur on or before such time; or (iii) by the Company,
if the Purchaser’s Closing conditions set forth in Section 2.4(a) have not been
satisfied or waived on or before June 11, 2010; provided, that the right to
terminate this Agreement under this Section 5.1(iii) shall not be available to
the Company whose failure to comply with its obligations under this Agreement
has been the cause of or resulted in the failure of the Closing to occur on or
before such time.

31

--------------------------------------------------------------------------------

In the event of a termination pursuant to this Section 5.1, each Purchaser shall
have the right to a return of up to its entire Purchase Price deposited with the
Escrow Agent pursuant to Section 2.1, without interest or deduction. In the
event of a termination pursuant to this Section 5.1, the Company shall promptly
notify all non-terminating Purchasers. Upon a termination in accordance with
this Section 5.1, the Company and the terminating Purchaser(s) shall not have
any further obligation or liability (including as arising from such termination)
to the other and no Purchaser will have any liability to any other Purchaser
under the Transaction Documents as a result therefrom.

5.2 Fees and Expenses. The Company acknowledges and agrees that it will pay out
of the Aggregate Purchase Price legal expenses incurred by ARC China for
drafting the Transaction Documents, in an amount up to $25,000. Except as
expressly set forth in the Transaction Documents to the contrary, each party
shall pay the fees and expenses of its advisers, counsel, accountants and other
experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement.
The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and
duties levied in connection with the delivery of any Securities to the
Purchasers.

5.3 Entire Agreement. The Transaction Documents, together with the exhibits and
schedules thereto, contain the entire understanding of the parties with respect
to the subject matter hereof and supersede all prior agreements and
understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and schedules.

5.4 Incorporation of Exhibits and Schedules. All schedules and exhibits hereto
which are referred to herein are hereby made a part hereof and incorporated
herein by such reference.

5.5 Notices. Any and all notices or other communications or deliveries required
or permitted to be provided hereunder shall be in writing and shall be deemed
given and effective on the earliest of (a) the date of transmission, if such
notice or communication is delivered via (i) facsimile (provided the sender
receives a machine-generated confirmation of successful transmission) at the
facsimile number specified in this Section or (ii) electronic mail (i.e., Email)
prior to 6:30 p.m. (New York City time) on a Trading Day, (b) the next Trading
Day after the date of transmission, if such notice or communication is delivered
via (i) facsimile at the facsimile number specified in this Section or (ii)
electronic mail (i.e., Email) on a day that is not a Trading Day or later than
6:30 p.m. (New York City time) on any Trading Day, or (c) the Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight
courier service, or (d) upon actual receipt by the party to whom such notice is
required to be given, if sent by any means other than facsimile or Email
transmission. The address for such notices and communications shall be as
follows:

32

--------------------------------------------------------------------------------

If to the Company: Nutrastar International Inc.   7/F (Jinhua Mansion)   41
Hanguang Street   Nangang District, Harbin,   Heilongjiang Province, P.R. China
150080   Attention: Han Lianyun   Facsimile: 86- 451-82287746     With a copy
to: Pillsbury Winthrop Shaw Pittman LLP   50 Fremont Street   San Francisco,
California 94105-2228   Attention: Scott C. Kline   Facsimile: (415) 983-1200

The Placement Agent shall be entitled to receive all notices related to the
Transaction Documents and the Offering.

If to the Placement Agent: Gilford Securities Incorporated,   777 Third Avenue,
17th Floor,   New York, New York 10017,   Attention: Corporate Finance,  
Facsimile: 212-223-1683       If to a Purchaser: To the address set forth under
such Purchaser’s name on  the signature pages hereof;

or such other address as may be designated in writing hereafter, in the same
manner, by such Person.

5.6 Amendments; Waivers. No provision of this Agreement may be waived, modified,
supplemented or amended except in a written instrument signed, in the case of an
amendment, by the Company and the Required Holders or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought. No
waiver of any default with respect to any provision, condition or requirement of
this Agreement shall be deemed to be a continuing waiver in the future or a
waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any party to exercise
any right hereunder in any manner impair the exercise of any such right.

5.7 Headings. The headings herein are for convenience only, do not constitute a
part of this Agreement and shall not be deemed to limit or affect any of the
provisions hereof.

5.8 Successors and Assigns. This Agreement shall be binding upon and inure to
the benefit of the parties and their successors and permitted assigns. The
Company may not assign this Agreement or any rights or obligations hereunder
without the prior written consent of each Purchaser (other than by merger). Any
Purchaser may assign any or all of its rights under this Agreement to any Person
to whom such Purchaser assigns or transfers any Securities or its rights to
acquire the Securities, including, but not limited to the registration rights
set forth in Section 4.17, provided that such transferee agrees to be bound,
with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the Purchasers.

33

--------------------------------------------------------------------------------

5.9 Third-Party Beneficiaries. This Agreement is intended for the benefit of the
parties hereto and their respective successors and permitted assigns and is not
for the benefit of, nor may any provision hereof be enforced by, any other
Person, except as otherwise set forth in Section 4.9.

5.10 Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of
Nevada, without regard to the principles of conflicts of law thereof. Each party
agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other
Transaction Documents (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, employees or agents) shall be
commenced exclusively in the state and federal courts sitting in the city of Las
Vegas, Nevada. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the city of Las Vegas,
Nevada, for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with
respect to the enforcement of any of the Transaction Documents), and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service
of process and consents to process being served in any such suit, action or
proceeding by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in
effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If either party shall commence an action
or proceeding to enforce any provisions of the Transaction Documents, then the
prevailing party in such action or proceeding shall be reimbursed by the other
party for its reasonable attorneys' fees and other costs and expenses incurred
with the investigation, preparation and prosecution of such action or
proceeding.

5.11 Survival. Sections 3.1, 3.2, Article IV, Sections 5.8 through 5.11 and 5.13
through 5.16 shall survive the Closing and the delivery of the Securities for
the applicable statute of limitations.

5.12 Execution. This Agreement may be executed in two or more counterparts, all
of which when taken together shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and
delivered to the other party, it being understood that both parties need not
sign the same counterpart. In the event that any signature is delivered by
facsimile transmission or by e-mail delivery of a ".pdf" format data file, such
signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if
such facsimile or ".pdf" signature page were an original thereof.

34

--------------------------------------------------------------------------------

5.13 Severability. If any term, provision, covenant or restriction of this
Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions set forth herein shall remain in full force and effect and shall in
no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to
achieve the same or substantially the same result as that contemplated by such
term, provision, covenant or restriction. It is hereby stipulated and declared
to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that
may be hereafter declared invalid, illegal, void or unenforceable.

5.14 Rescission and Withdrawal Right. Notwithstanding anything to the contrary
contained in (and without limiting any similar provisions of) any of the other
Transaction Documents, whenever any Purchaser exercises a right, election,
demand or option under a Transaction Document and the Company does not timely
perform its related obligations within the periods therein provided, then such
Purchaser may rescind or withdraw, in its sole discretion from time to time upon
written notice to the Company, any relevant notice, demand or election in whole
or in part without prejudice to its future actions and rights.

5.15 Replacement of Securities. If any certificate or instrument evidencing any
Securities is mutilated, lost, stolen or destroyed, the Company shall issue or
cause to be issued in exchange and substitution for and upon cancellation
thereof (in the case of mutilation), or in lieu of and substitution therefor, a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction. The applicant
for a new certificate or instrument under such circumstances shall also pay any
reasonable third-party costs (including customary indemnity) associated with the
issuance of such replacement Securities.

5.16 Remedies. In addition to being entitled to exercise all rights provided
herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction
Documents. The parties agree that monetary damages may not be adequate
compensation for any loss incurred by reason of any breach of obligations
contained in the Transaction Documents and hereby agrees to waive and not to
assert in any action for specific performance of any such obligation the defense
that a remedy at law would be adequate.

5.17 Payment Set Aside. To the extent that the Company makes a payment or
payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the
proceeds of such enforcement or exercise or any part thereof are subsequently
invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored
to the Company, a trustee, receiver or any other person under any law
(including, without limitation, any bankruptcy law, state or federal law, common
law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been
made or such enforcement or setoff had not occurred.

35

--------------------------------------------------------------------------------

5.18 Independent Nature of Purchasers' Obligations and Rights. The obligations
of each Purchaser under any Transaction Document are several and not joint with
the obligations of any other Purchaser, and no Purchaser shall be responsible in
any way for the performance or non-performance of the obligations of any other
Purchaser under any Transaction Document. Nothing contained herein or in any
other Transaction Document, and no action taken by any Purchaser pursuant
thereto, shall be deemed to constitute the Purchasers as a partnership, an
association, a joint venture or any other kind of entity, or create a
presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the
Transaction Documents. Each Purchaser shall be entitled to independently protect
and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be
necessary for any other Purchaser to be joined as an additional party in any
proceeding for such purpose. Each Purchaser has been represented by its own
separate legal counsel in their review and negotiation of the Transaction
Documents to which it is a party. For reasons of administrative convenience
only, Purchasers and their respective counsel have chosen to communicate with
the Company through ARC China or Brownstein. Brownstein does not represent the
Purchasers but only ARC China. The Company has elected to provide all Purchasers
with the same terms and Transaction Documents for the convenience of the Company
and not because it was required or requested to do so by the Purchasers.

5.19 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be
exercised on the next succeeding Business Day.

5.20 Construction. Whenever required by the context of this Agreement, the
singular shall include the plural and the plural shall include the singular. The
parties agree that each of them and/or their respective counsel has reviewed and
had an opportunity to revise the Transaction Documents to which they are a party
and, therefore, the normal rule of construction to the effect that any
ambiguities are to be resolved against the drafting party shall not be employed
in the interpretation of the Transaction Documents to which they are a party or
any amendments hereto.

5.21 WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY
JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH
KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW,
HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER
TRIAL BY JURY.

(Signature Pages Follow)

 

 

36

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.

Nutrastar International Inc.

  Address for Notice:       7/F (Jinhua Mansion) By:
__________________________________________ 41 Hanguang Street        Name: Han
Lianyun Nangang District, Harbin        Title: Chief Executive Officer and
Chairperson Heilongjiang Province   P.R. China 150080     With a copy to (which
shall not constitute notice):       Pillsbury Winthrop Shaw Pittman LLP   Scott
C. Kline   50 Fremont Street   San Francisco, CA 94105-2228  

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE PAGES FOR PURCHASERS FOLLOWS]

 

 

37

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.

Name of Purchaser: ________________________________________________
(Exact name as it should appear in the records of the Company and any
registration statement in which Purchaser is named "selling stockholder)

Signature of Authorized Signatory of Purchaser: _________________________
Name and Title of Authorized Signatory: _______________________________
Title of Authorized Signatory: _______________________________________
Email Address of Authorized Signatory: _______________________________
Fax Number of Authorized Signatory: _________________________________

Address for Notice of Purchaser:

Purchase Price ($28.56 per Unit): _____________________________________
Number of Units: ________________________________________________

Social Security or Tax ID Number (or foreign equivalent): __________________
(Purchaser may alternatively provide a copy of a validly issued identification
card or passport of the Authorized Signatory)

Please also complete the following:

Purchaser is a broker-dealer registered under Section 15 of the Exchange Act:
Yes ___ No ___
Purchaser is an affiliate of a broker-dealer: Yes ___ No ___
If the answer is yes, please explain the nature of any such relationship:

Please describe any material relationship with the Company or any of its
officers within the past three years:

Please describe all other securities of the Company that Purchaser beneficially
owns:

Please describe any arrangements made or known relating to the distribution of
any shares of the Company's common stock under any registration statement,
including the amount of such arrangements:

If Purchaser is an entity, please list all natural persons with the power to
vote or dispose of the Securities being purchased:

 

[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]

 

 

38

--------------------------------------------------------------------------------

PURCHASER QUESTIONNAIRE

Non-U.S. Persons:

(A) ____ The Purchaser hereby represents and warrants that the Purchaser IS NOT
a U.S. domestic Person.             U.S. Persons:       (B) ____ The Purchaser
hereby represents and warrants that the Purchaser IS a U.S. domestic Person.
(Please also indicate which category of Accredited Investor is applicable)      
The Purchaser hereby represents and warrants that the Purchaser is an Accredited
Investor as a result of satisfying the requirements of the paragraphs below to
which the Subscriber has indicated.           (1) ____ any bank as defined in
Section 3(a)(2) of the Securities Act or any savings and loan association or
other institution as defined in Section 3(a)(5)(A) of  the Securities Act
whether acting in its individual or fiduciary capacity;       (2) ____  any
broker or dealer registered pursuant to Section 15 of the Exchange Act;      
(3) ____  any insurance company as defined in Section 2(a)(13) of the Securities
Act;       (4) ____ any investment company registered under the Investment
Company Act of 1940, as amended, or a business development company as defined in
Section 2(a)(48) of that Act;       (5) ____  any small business investment
company licensed by the U.S. Small Business Administration under Section 301(c)
or (d) of the Small Business Investment Act of 1958;       (6) ____  any plan
established and maintained by a state, its political subdivisions, or any agency
or instrumentality of a state or its political subdivisions, for the benefit of
its employees, if such plan has total assets in excess of $5,000,000;

39

--------------------------------------------------------------------------------

(7) ____ any employee benefit plan within the meaning of the Employee Retirement
Income Security Act of 1974, if the investment decision is made by a plan
fiduciary, as defined in Section 3(21) of such Act, which is either a bank,
savings and loan association, insurance company, or registered investment
adviser, or if the employee benefit plan has total assets in excess of
$5,000,000, or, if a self-directed plan, with investment decisions made solely
by persons that are Accredited Investors;       (8) ____  any private business
development company as defined in Section 202(a)(22) of the Investments Advisers
Act of 1940;       (9) ____  any organization described in section 501(c)(3) of
the Internal Revenue Code of 1986, as amended, corporation, Massachusetts or
similar business trust, or partnership not formed for the specific purpose of
acquiring the Securities, with total assets in excess of $5,000,000;       (10)
____  a director or executive officer of the issuer of the securities being
offered or sold;       (11) ____  a natural person that has a net worth (or
joint net worth together with his or her spouse) in excess of $1,000,000;      
(12) ____  a natural person that had annual gross income during the last two
full calendar years in excess of $200,000 (or together with his or her spouse in
excess of $300,000 in each of those years) and reasonably expects to have annual
gross income in excess of $200,000 (or together with his or her spouse in excess
of $300,000) during the current calendar year;       (13) ____ any trust with
total assets in excess of $5,000,000, not formed for the specific purpose of
acquiring the Securities, whose purchase is directed by a sophisticated person,
as defined in Rule 506(b)(2)(ii) of the Securities Act; or       (14) ____ any
entity in which all the equity owners are within one or more of the foregoing
categories.

Terms used in this signature page have the meanings given them in the Agreement
unless otherwise defined herein.

[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]

 

 

40

--------------------------------------------------------------------------------